Annual Working Capital
$57.65 M
-$20.98 M-26.68%
December 31, 2022
Summary
- As of February 10, 2025, IMPL annual working capital is $57.65 million, with the most recent change of -$20.98 million (-26.68%) on December 31, 2022.
- During the last 3 years, IMPL annual working capital has risen by +$26.44 million (+84.75%).
Performance
IMPL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
-$101.32 M
-$13.00 M-14.72%
September 1, 2023
Summary
- As of February 10, 2025, IMPL quarterly working capital is -$101.32 million, with the most recent change of -$13.00 million (-14.72%) on September 1, 2023.
- Over the past year, IMPL quarterly working capital has dropped by -$180.63 million (-227.74%).
Performance
IMPL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
IMPL Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.7% | -227.7% |
| 3 y3 years | +84.8% | - |
| 5 y5 years | +84.8% | - |
IMPL Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.7% | at low | -185.7% | at low |
| 5 y | 5-year | -26.7% | -104.1% | -185.7% | at low |
| alltime | all time | -26.7% | -104.1% | -185.7% | at low |
Impel Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$101.32 M(+14.7%) |
| Jun 2023 | - | -$88.32 M(-398.3%) |
| Mar 2023 | - | $29.60 M(-48.6%) |
| Dec 2022 | $57.65 M | $57.65 M(-27.3%) |
| Sep 2022 | - | $79.31 M(-17.5%) |
| Jun 2022 | - | $96.14 M(-18.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $118.20 M(+50.3%) |
| Dec 2021 | $78.62 M(-3439.9%) | $78.62 M(-22.8%) |
| Sep 2021 | - | $101.89 M(+80.2%) |
| Jun 2021 | - | $56.56 M(-892.7%) |
| Mar 2021 | - | -$7.13 M(+203.1%) |
| Dec 2020 | -$2.35 M(-107.5%) | -$2.35 M |
| Dec 2019 | $31.20 M | - |
FAQ
- What is Impel Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals annual working capital year-on-year change?
- What is Impel Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals quarterly working capital year-on-year change?
What is Impel Pharmaceuticals annual working capital?
The current annual working capital of IMPL is $57.65 M
What is the all time high annual working capital for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high annual working capital is $78.62 M
What is Impel Pharmaceuticals annual working capital year-on-year change?
Over the past year, IMPL annual working capital has changed by -$20.98 M (-26.68%)
What is Impel Pharmaceuticals quarterly working capital?
The current quarterly working capital of IMPL is -$101.32 M
What is the all time high quarterly working capital for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high quarterly working capital is $118.20 M
What is Impel Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, IMPL quarterly working capital has changed by -$180.63 M (-227.74%)